For the quarter ended September 30, 2021 (Q2 FY2022), AstraZeneca's total income was Rs 200.5509 crore, against Rs 214.1896 crore in the corresponding quarter of the previous year (YoY) and Rs 178.3018 crore in the previous quarter (QoQ).

For the quarter ended September 30, 2021 (Q2 FY2022), the company's net profit was Rs 11.9470 crore, against Rs 26.3384 crore in the corresponding quarter of the previous year (YoY) and Rs 10.2433 crore in the previous quarter (QoQ).

For the 6 months ended September 30, 2021(Half Year Ended FY 2022), the company's total income was Rs 378.8527 crore, against Rs 410.4152 crore in the previous year (YoY) (Half Year Ended FY 2021).

The net profit was at  Rs 22.1903 crore for the 6 months ended September 30, 2021 (Half Year Ended FY 2022), compared to Rs 44.9731 crore in the previous year (YoY) (Half Year Ended FY 2021).